Prosecution Insights
Last updated: October 02, 2026

Examiner: BRANDT, DAVID NELSON

Tech Center 4100 • Art Units: 3746 3783 4100

This examiner grants 70% of resolved cases

Analysis

David Nelson Brandt is an examiner in Tech Center 4100 who has resolved 375 cases. His allowance rate pct of 70.1% in Art Unit 3746 is quite high, suggesting that he is generally open to granting patents. The median days to allowance is 958, which is a relatively efficient timeline for applicants in this technical area.

The most notable data point is the interview lift pct of 49.0. This is an exceptionally high lift, indicating that interviews are incredibly effective at moving applications toward an allowance. For practitioners, this means that an interview should be a standard part of the prosecution strategy for every case assigned to this examiner. The combination of a 70.1% allowance rate and a 49.0% interview lift makes this a very favorable profile for applicants, provided they engage in direct dialogue during the 958-day median prosecution cycle.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

70.1%
Allow Rate
+10.1% vs TC avg
419
Total Applications
+49.0%
Interview Lift
958
Avg Prosecution Days
Based on 375 resolved cases, 2023–2026

Rejection Statute Breakdown

1.0%
§101 Eligibility
19.5%
§102 Novelty
40.4%
§103 Obviousness
37.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18289526 TISSUE RESECTION SYSTEMS INCLUDING FLUID OUTFLOW MANAGEMENT Non-Final OA Covidien LP
18402840 FLUID PUMP HOUSING SECTION HAVING ONE OR MORE JOINING FLANGES COLLECTIVELY EXTENDING ALONG A SUBSTANTIAL PERCENTAGE OF A CIRCUMFERENCE THEREOF Final Rejection Halliburton Energy Services, Inc.
18370060 DETERMINING ANGULAR POSITION OF A ROTOR IN A DOWNHOLE ELECTRIC SUBMERSIBLE PUMP (ESP) ELECTRIC MOTOR Non-Final OA Halliburton Energy Services, Inc.
17074405 Rapidly Insertable Central Catheter and Methods Thereof Non-Final OA Bard Access Systems, Inc.
18266316 A BREAST PUMP Final Rejection KONINKLIJKE PHILIPS N.V.
18279785 AID TO BE APPLIED TO NEEDLELESS SYRINGE, NEEDLELESS SYRINGE PROVIDED WITH AID, AND INTRADERMAL INJECTION METHOD Non-Final OA DAICEL CORPORATION
18270771 INJECTOR Final Rejection DAICEL CORPORATION
18565378 FUEL PUMP Final Rejection MITSUBISHI HEAVY INDUSTRIES ENGINE & TURBOCHARGER, LTD.
18361237 SLOTTED LINERS FOR MEDICAL DEVICE Non-Final OA Maduro Discovery, LLC
18262904 LARGE DIAMETER HEMOSTASIS VALVES Non-Final OA NEPTUNE MEDICAL INC.
17419415 Compressor Non-Final OA Hitachi Industrial Equipment Systems Co., Ltd.
18670146 Torosional Non-Disconnecting Luer Connector Non-Final OA Becton, Dickinson and Company
18684130 Smart Monitoring of an Intravenous Access Site Using Sensors for Continuous Monitoring Non-Final OA Becton, Dickinson And Company
18023434 ROTATIONAL METERING PUMP WITH CAM-DRIVEN VALVING SHUTTLE INTERLOCK Final Rejection Becton, Dickinson and Company
18288449 Housing Components for an Injection Device Non-Final OA Sanofi
18434440 REUSABLE INJECTION APPARATUS AND METHOD Non-Final OA Purdue Research Foundation
18250524 SYRINGE GASKET AND SYRINGE Final Rejection SUMITOMO RUBBER INDUSTRIES, LTD.
18472929 CONTINUOUS ADMINISTRATION DEVICE Non-Final OA TERUMO KABUSHIKI KAISHA
18039433 ADMINISTRATION DEVICE FOR IN PARTICULAR INTRAVITREAL ADMINISTRATION OF A FLUID Final Rejection BOEHRINGER INGELHEIM INTERNATIONAL GMBH
18368242 FRICTIONLESS DESIGN OF HIGH-PRESSURE RECIRCULATION THERMO-PUMP Non-Final OA KLA Corporation
18281377 Access System Including Flexible Needle Non-Final OA Bard Peripheral Vascular, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month